Insufficient scRNA-seq data for expression of OLAH at single-cell level.
Insufficient scRNA-seq data for expression of OLAH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 87% | 806.17 | 209 / 241 | 0% | 0 | 0 / 0 |
thymus | 24% | 15.47 | 157 / 653 | 61% | 2.46 | 369 / 605 |
kidney | 79% | 77.74 | 70 / 89 | 2% | 0.14 | 17 / 901 |
blood vessel | 78% | 111.89 | 1036 / 1335 | 0% | 0 | 0 / 0 |
adipose | 70% | 91.22 | 846 / 1204 | 0% | 0 | 0 / 0 |
lung | 63% | 159.94 | 365 / 578 | 5% | 0.20 | 60 / 1155 |
esophagus | 59% | 210.25 | 848 / 1445 | 8% | 0.33 | 15 / 183 |
breast | 58% | 127.47 | 266 / 459 | 9% | 0.88 | 96 / 1118 |
adrenal gland | 62% | 54.05 | 160 / 258 | 4% | 0.15 | 10 / 230 |
peripheral blood | 65% | 3988.59 | 608 / 929 | 0% | 0 | 0 / 0 |
skin | 37% | 75.67 | 676 / 1809 | 3% | 1.55 | 13 / 472 |
uterus | 34% | 28.50 | 57 / 170 | 2% | 0.05 | 10 / 459 |
stomach | 18% | 17.34 | 66 / 359 | 6% | 0.18 | 17 / 286 |
brain | 19% | 11.32 | 494 / 2642 | 5% | 0.11 | 38 / 705 |
intestine | 22% | 17.05 | 208 / 966 | 2% | 0.05 | 11 / 527 |
prostate | 21% | 15.16 | 52 / 245 | 0% | 0.00 | 2 / 502 |
bladder | 14% | 8.19 | 3 / 21 | 1% | 0.03 | 7 / 504 |
ovary | 14% | 15.43 | 26 / 180 | 1% | 0.02 | 4 / 430 |
liver | 12% | 11.39 | 27 / 226 | 2% | 0.10 | 9 / 406 |
heart | 8% | 5.24 | 68 / 861 | 0% | 0 | 0 / 0 |
pancreas | 2% | 1.61 | 8 / 328 | 2% | 0.04 | 4 / 178 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
muscle | 3% | 1.53 | 21 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051792 | Biological process | medium-chain fatty acid biosynthetic process |
GO_0008610 | Biological process | lipid biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0016297 | Molecular function | fatty acyl-[ACP] hydrolase activity |
Gene name | OLAH |
Protein name | oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14) Oleoyl-ACP hydrolase S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Augmented in rheumatoid arthritis 1) (AURA1) (Oleoyl-ACP hydrolase) (Thioesterase 2) (TE2) (Thioesterase II) (Thioesterase domain-containing protein 1) |
Synonyms | THEDC1 |
Description | FUNCTION: Contributes to the release of free fatty acids from fatty acid synthase (FASN). Has broad substrate specificity, giving rise to a range of free fatty acids with chain lengths between 10 and 16 carbon atoms (C10 - C16). . |
Accessions | Q5VUB9 Q5VUC0 ENST00000413672.5 ENST00000378228.8 [Q9NV23-1] ENST00000428897.5 Q9NV23 Q5VUC1 ENST00000378225.5 ENST00000378217.3 [Q9NV23-2] Q5VUB8 ENST00000429028.5 |